UBS Group’s Audentes Therapeutics, Inc BOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-752,003
| Closed | -$45M | – | 7581 |
|
|
2019
Q4 | $45M | Buy |
752,003
+650,385
| +640% | +$38.9M | 0.02% | 643 |
|
|
2019
Q3 | $2.85M | Buy |
101,618
+66,938
| +193% | +$1.88M | ﹤0.01% | 2319 |
|
|
2019
Q2 | $1.31M | Buy |
34,680
+6,180
| +22% | +$234K | ﹤0.01% | 2839 |
|
|
2019
Q1 | $1.11M | Sell |
28,500
-98,990
| -78% | -$3.86M | ﹤0.01% | 2852 |
|
|
2018
Q4 | $2.72M | Buy |
127,490
+118,660
| +1,344% | +$2.53M | ﹤0.01% | 2175 |
|
|
2018
Q3 | $350K | Sell |
8,830
-678
| -7% | -$26.9K | ﹤0.01% | 3865 |
|
|
2018
Q2 | $364K | Sell |
9,508
-41,024
| -81% | -$1.57M | ﹤0.01% | 3757 |
|
|
2018
Q1 | $1.52M | Buy |
50,532
+41,696
| +472% | +$1.25M | ﹤0.01% | 2723 |
|
|
2017
Q4 | $276K | Buy |
8,836
+1,020
| +13% | +$31.9K | ﹤0.01% | 3821 |
|
|
2017
Q3 | $219K | Buy |
7,816
+7,219
| +1,209% | +$202K | ﹤0.01% | 3949 |
|
|
2017
Q2 | $11K | Buy |
597
+580
| +3,412% | +$10.7K | ﹤0.01% | 5798 |
|
|
2017
Q1 | $0 | Buy |
+17
| New | – | ﹤0.01% | 6964 |
|
|
2016
Q4 | – | Sell |
-1,394
| Closed | -$25K | – | 7020 |
|
|
2016
Q3 | $25K | Buy |
+1,394
| New | +$25K | ﹤0.01% | 5230 |
|